Questcor Pharmaceuticals Inc. declined for a second straight day after a research report said that the company’s multiple sclerosis treatment didn’t contain any of its active ingredient.
The shares of the Anaheim, California-based company fell 10 percent to close at $60.75 in New York, the biggest single-day loss in about four months. Yesterday, shares tumbled 9.1 percent.
